Ares Allergy and Stallergenes €1 billion merger

Overview:

• Pharmaceutical company Stallergenes completed its merger with Ares Allergy, the parent company of Greer Laboratories, to form a global leading force in the allergen immunotherapy field. 
• The merged company is known as Stallergenes Greer. 
• The merger was valued at around €1 billion, based on a combined turnover of €312.5 million.
• This was the first example of a merger between a French listed company and a UK company under the European Merger Directive.

John Crabb- Journalist